Clemson University spin-off, Kiyatec, LLC, participates in Innovation and Entrepreneurship Showcase on Capitol Hill

KIYATEC, Inc., a Clemson-based company, was selected to participate in The University Innovation and Entrepreneurship Showcase that took place on Capitol Hill on April 10. The event, hosted by the Association of Public and Land-grant Universities (APLU) and the Association of American Universities (AAU), recognizes the impact that federally-funded research has on driving entrepreneurship and innovation. 

KIYATEC’S innovative research on 3D cell culture began at Clemson University. Their ex vivo 3D cell culture technology allows accurate modeling and prediction of cancer patient response to drug therapies. KIYATEC’S validated process uses cancer cells taken from patients via surgical or biopsy tissues to create a life-like replication in order to determine what treatments the patient will respond to prior to beginning the treatment.  

Startups for the showcase were chosen based on the level of student engagement in the startup, the strength of the technology the startup produces, and its relationship to research. For more information on KIYATEC, click here

SCRA-led team awarded grant to increase commercialization of medical devices

Written by   in 

An SCRA-led team was recently awarded a federal grant by the U.S. Economic Development Administration (EDA) as part of the 2018 Regional Innovation Strategies Competition. An award of approximately $750,000, the grant will fund the creation of the South Carolina Medical Device Alliance (MDA). As a collaborative effort between the Medical University of South Carolina, Clemson University, and industry leaders, the Medical Device Alliance will be used to grow the economic impact of the medical device industry through promoting the development of products, supporting the formation of startups, and increasing the commercialization of medical devices.

“The South Carolina Medical Device Alliance brings together a wide variety of life science expertise throughout the state to support commercialization of innovative, early-stage medical technologies coming out of our research institutions,” said Chris Gesswein, Executive Director of the Clemson University Research Foundation. “This program will embed industry knowledge and expertise early in the development phase to ensure that the medical device technologies it supports address validated market needs, which is critical to successful commercialization.”

In an effort to grow the economic impact of the medical sector, the MDA will advance medical technologies to the market by designing solutions, determining initial feasibility, de-risking innovations with multidisciplinary teams, and launching startups that have been evaluated by industry experts.                      

To learn more about the South Carolina Medical Device Alliance, click here

Recovr, Inc. receives SC Launch, Inc. investment from SCRA

 Recovr, Inc., a Clemson-based company, has worked to provide alternative therapy options for post-stroke survivors who suffer from arm-impairment. In 2013, Recovr was founded by Clemson researchers who licensed their initial stroke research done at Clemson and MUSC through the Clemson University Research Foundation (CURF). Led by Austen Hayes, a member of the original development team, as the CEO, their current product, the Recovr Rehabilitation System (RRS), has now expanded to support therapy of a wide range of physical and neurological conditions while also capturing and automatically documenting a patient’s progress and compliance with their rehabilitation program. 

Recently, Recovr has received an investment from SC Launch, Inc. of the South Carolina Research Authority (SCRA). Totaling $200,000, the investment will allow Recovr to expand their sales and fund further development of Recovr’s Telerehabilitation Platform that will enable providers to enhance outcomes and decrease costs with home-based rehabilitation. 

For more information on Recovr and the SC Launch investment, click here.